From a pathophysiological perspective, immune checkpoint molecules (PD-1 on T lymphocytes and PD-L1 on tumor cells) release cellular signals (immunological checkpoints) that inhibit T lymphocyte proliferation and anti-tumor activity. This evidence concerns the gene CD274 and neoplasm.